Skip to main content

Table 1 Baseline characteristics of study population based on imputation dataset 1

From: Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort

 

SDPTs n = 811

%

No-SDPTs n = 9983

%

Age

 Mean (SD)

69.83 (7.07)

 

68.06 (7.89)

 

 < 63

133

16.40

2693

26.98

 63–67.99

191

23.55

2417

24.21

 68–73.99

253

31.20

2542

25.46

 > 74

234

28.85

2331

23.35

Education

 High

226

27.87

3132

31.37

 Middle

352

43.40

4088

40.95

 Low/no

222

27.37

2619

26.23

 Missing data

11

1.36

144

1.44

Glucose (mmol/L)

 Mean (SD)

5.10 (1.28)

 

5.09 (1.19)

 

 > 6.11

54

6.66

661

6.62

 < 6.11

724

89.27

8672

86.87

 Missing data

33

4.07

650

6.51

Triglycerides (mmol/L)

 Mean (SD)

1.64 (1.26)

 

1.53 (1.06)

 

 > 1.71

270

33.29

2751

27.56

 < 1.71

530

65.35

7028

70.40

 Missing data

11

1.36

204

2.04

Cholesterol (mmol/L)

 Mean (SD)

6 (1.02)

 

5.91 (1.05)

 

 > 6.5

275

33.91

2797

28.02

 < 6.5

526

64.86

7016

70.28

 Missing data

10

1.23

170

1.70

Fructosamine (mmol/L)

 Mean (SD)

2.11 (0.32)

 

2.11 (0.26)

 

 > 2.5

31

3.82

296

2.97

 < 2.5

575

70.90

7307

73.19

 Missing data

205

25.28

2380

23.84

GGT (IU/L)

 Mean (SD)

36.98 (97.36)

 

32.30 (35.29)

 

 > 36

69

8.51

701

7.02

 < 36

688

84.83

8424

84.38

 Missing data

54

6.66

858

8.59

CCI at Pca dx

 0

606

74.72

7705

77.18

 1

131

16.15

1451

14.53

 2

45

5.55

466

4.67

 3+

29

3.58

361

3.62

Diabetes at PCdx

 Yes

42

5.18

418

4.19

 No

769

94.82

9565

95.81

 FUT

3.77 (2.83)

 

5.28 (3.22)

 

Treatment

 RT

101

12.45

1040

10.42

 RP

175

21.58

2936

29.41

 HT

206

25.40

2211

22.15

 DT (AS WW)

231

28.48

2332

23.36

 Unspecified

55

6.78

823

8.24

 Missing data

43

5.30

641

6.42

Stage group

 Low risk

205

25.28

3140

31.45

 Intermediate risk

251

30.95

2791

27.96

 High risk

225

27.74

2220

22.24

 Regionally metastatic

41

5.06

567

5.68

 Distant metastases

59

7.27

928

9.30

 Missing data

30

3.70

336

3.37

  1. Abbreviations: GGT gamma glutamyl transferase; PCa prostate cancer; SDPTs secondly diagnosed primary tumours; CCI Charlson comorbidity index; FUT follow up time; RT Radiotherapy; RP radical prostatectomy; HT hormonal treatment, DT: deferred treatment